| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/05/2006 | WO2006002236A1 N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | WO2006001750A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | WO2006000589A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 01/05/2006 | WO2006000312A1 Pesticidal n-phenylpyrazole derivatives |
| 01/05/2006 | WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004084 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 01/05/2006 | US20060004081 Cytotoxic compounds and conjugates |
| 01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004047 Piperidine derivatives as ccr5 inhibitors |
| 01/05/2006 | US20060004044 3-glyoxylamideindoles for treating cancer |
| 01/05/2006 | US20060004033 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 01/05/2006 | US20060004029 Nitrogen-containing aromatic derivatives |
| 01/05/2006 | US20060004022 4-, 5-, 6- And 7-indole derivatives useful for the treatment of CNS disorders |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060004005 Triazines derivatives as cell adhesion inhibitors |
| 01/05/2006 | US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps |
| 01/05/2006 | US20060002853 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 01/05/2006 | DE69828607T2 CHINOLIN- UND CHINOXALIN-VERBINDUNGEN DIE DEN VON BLUTPLÄTTCHEN ABSTAMMMENDEN WACHSTUMSFAKTOR UND/ODER PDGF- UND P56lck-TYROSIN-KINASE HEMMEN Quinoline and quinoxaline THE COMPOUNDS OF THE PLATELET FACTOR ABSTAMMMENDEN GROWTH AND / OR PDGF-TYROSINE KINASE AND p56 HEMMEN |
| 01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
| 01/05/2006 | CA2810655A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2572328A1 2-aminoarylcarboxamides useful as cancer chemotherapeutic agents |
| 01/05/2006 | CA2572135A1 Sulfonamide compound |
| 01/05/2006 | CA2571949A1 Modulators of atp-binding cassette transporters |
| 01/05/2006 | CA2571002A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | CA2570893A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
| 01/05/2006 | CA2570873A1 Pyrimidine urea derivatives as kinase inhibitors |
| 01/05/2006 | CA2570673A1 Compounds and methods for treating dyslipidemia |
| 01/05/2006 | CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | CA2570552A1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
| 01/04/2006 | EP1612208A2 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/04/2006 | EP1611126A1 Chromenone indoles |
| 01/04/2006 | EP1611122A1 Substituted pyrazole compounds |
| 01/04/2006 | EP1611121A1 Pyridazinone derivatives as cdk2-inhibitors |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611119A1 Pi-3 kinase inhibitor prodrugs |
| 01/04/2006 | EP1611109A1 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/04/2006 | EP1611107A1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders |
| 01/04/2006 | EP1611105A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 01/04/2006 | EP1611104A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 01/04/2006 | EP1611094A1 Pyrazole compounds |
| 01/04/2006 | EP1611090A2 Cannabinoid receptor ligands |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610786A1 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 01/04/2006 | EP1610776A2 Ophthalmic compositions for treating ocular hypertension |
| 01/04/2006 | EP1610774A2 Tie-2 modulators and methods of use |
| 01/04/2006 | EP1546391A4 Energy transfer dyes, terminators and use thereof |
| 01/04/2006 | EP1546125A4 Fluorescent labeling reagents with multiple donors and acceptors |
| 01/04/2006 | EP1409455B1 Prostaglandin analogues-as ep4 receptor agonists |
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1339677B1 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP1147088B1 6-arylphenanthridines with pde-iv inhibiting activity |
| 01/04/2006 | EP0885885B1 Pyridone derivatives and herbicides |
| 01/04/2006 | CN1717405A Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 01/04/2006 | CN1717404A 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/04/2006 | CN1717396A Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 01/04/2006 | CN1717389A Phenyl substituted piperidine compounds for use as PPAR activators |
| 01/04/2006 | CN1234702C Benzopyran compound, and pharmaceutical composition including them |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/03/2006 | US6982338 Oxetane compounds containing maleimide functionality |
| 01/03/2006 | US6982272 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 01/03/2006 | CA2247451C Carboxylic acid derivatives having fused rings as retinoic acid receptor agonist |
| 01/03/2006 | CA2244695C Cyclic amic acid derivatives |
| 01/03/2006 | CA2135852C 5-methyluridine process for large-scale preparation of 2',3'-didehydro-3'-deoxythymidine (d4t) |
| 01/03/2006 | CA2117651C Itraconazole and saperconazole stereoisomers |
| 12/29/2005 | WO2005123727A1 3-aryl-3-hydroxy- and 3-aryl-3-oxopropionic acid esters as fungicides |
| 12/29/2005 | WO2005123724A1 2,4-diaminoquinazolines for spinal muscular atrophy |
| 12/29/2005 | WO2005123719A1 Compounds and compositions as protein kinase inhibitors |
| 12/29/2005 | WO2005123718A2 Benzimidazolone carboxylic acid derivatives |
| 12/29/2005 | WO2005123716A1 Indole derivatives as histamine receptor antagonists |
| 12/29/2005 | WO2005123708A1 Recovery of optically active epoxy alcohols |
| 12/29/2005 | WO2005123697A1 Quinazoline derivatives |
| 12/29/2005 | WO2005123696A1 Substituted quinazolones as anti-cancer agents |
| 12/29/2005 | WO2005123695A1 Process for producing iminoquinazolinone derivative |
| 12/29/2005 | WO2005123693A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 12/29/2005 | WO2005123688A2 3-aminoindazoles |
| 12/29/2005 | WO2005123687A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 12/29/2005 | WO2005123671A1 Pyrrole derivative |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005122768A1 Substituted benzoylpyrazoles used as herbicides |
| 12/29/2005 | WO2005115384A3 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
| 12/29/2005 | WO2005086656A3 Heteroarylaminopyrazole derivatives useful for the treatment of diabetes |
| 12/29/2005 | WO2005012294A8 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases |
| 12/29/2005 | US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides |
| 12/29/2005 | US20050288358 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors |
| 12/29/2005 | US20050288357 e.g. 4-(2-{2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxopyrrolidin-1-yl}ethyl)benzoic acid; antiinflammatory, hypotensive, antiulcer agent |
| 12/29/2005 | US20050288354 peroxisome proliferator activated receptor scaffold and modulator; 3-[1-(4-butoxy-benzenesulfonyl)-5-metoxy-1H-indol-3-yl]-propionic acid methyl etster; for identification or development of additional active compound; bioassay: binding affinity or specificity; antidiabetic, obesity, metabolic disorder |
| 12/29/2005 | US20050288350 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer; 6-(bis-2,2,2-Trifluoroethyl)amino-4-trifluoromethylcoumarin |
| 12/29/2005 | US20050288347 Certain triazole-based compounds, compositions, and uses thereof |
| 12/29/2005 | US20050288335 Triamide-substituted heterobicyclic compounds |
| 12/29/2005 | US20050288321 Alzheimer's disease ; 3-(2,3-dihydro-5,6-difluorobenzofur-7-yl)-4-[1-(piperidin-4-yl)-1H-indol-3-yl]pyrrole-2,5-dione; stimulating bone deposition |
| 12/29/2005 | US20050288315 4-((7-chloroquinolin-4-yl)aminoalkyleneamino-)-spiro(cyclohexane-1.5'-1H-4,5,6-trioxaindene )dicitrate; malaria; paraciticides; antiprotozoa agents; Plasmodium; synergistic; chloroquine-resistant; cost efficiency; industrial scale; penetration and activity of artemisine |